RxDoctor Payments Data

Ashley Langford Tunkle, MD

Family Medicine · Naples, FLNPI 1285603670

Payments from drug & device makers

$17,365in general payments, 2019–2025

Across 952 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Astellas Pharma US Inc$1K
  • Johnson & Johnson$950
  • Amgen$929
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$17,00498%
  • Education$3612%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer120$2,115
AbbVie(2 entities)105$1,764
Novo Nordisk73$1,430
Astellas Pharma US Inc51$1,082
Johnson & Johnson63$950
Amgen(2 entities)48$929
Lilly USA, LLC50$809
Merck39$772
AstraZeneca35$702
Takeda Pharmaceuticals U.S.A., Inc.33$537
GSK32$505
Boehringer Ingelheim32$453
Supernus Pharmaceuticals, Inc.26$452
Novartis11$311
Corium, LLC14$294
Esperion Therapeutics, Inc.16$273
Exact Sciences11$269
Boston Scientific8$243
Ironshore Pharmaceuticals Inc.11$222
Abbott11$218
Jazz Pharmaceuticals Inc.11$187
Sunovion Pharmaceuticals Inc.9$180
Kaleo, Inc.11$154
Sumitomo Pharma America, Inc.6$145
Bayer5$134
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$125
Almatica Pharma LLC7$120
Shire North American Group Inc11$120
Alnylam Pharmaceuticals Inc.4$103
Sanofi Pasteur Inc.4$100
Teva Pharmaceuticals USA, Inc.6$99
Biohaven Pharmaceuticals, Inc.5$97
Therapeuticsmd, Inc.5$91
Amarin Pharma, Inc.4$87
Teleflex LLC1$86
Idorsia Pharmaceuticals US Inc4$78
Biohaven Pharmaceutical Holding Company Ltd.4$77
Otsuka America Pharmaceutical, Inc.3$75
Phathom Pharmaceuticals, Inc.6$74
Medtronic1$74
IBSA Pharma Inc.4$63
Vivus LLC3$55
Tris Pharma Inc3$54
Kowa Pharmaceuticals America, Inc.3$45
Genentech USA, Inc.2$38
Neos Therapeutics, LP2$36
Radius Health, Inc.2$35
Si-bone, Inc.1$34
Sanofi-aventis U.S. LLC2$34
Eisai Inc.2$33
Amneal Pharmaceuticals LLC2$32
AMAG Pharmaceuticals, Inc.2$31
Bausch Health US, LLC1$24
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$22
Organon1$22
Evofem Biosciences, Inc.1$21
Xeris Pharmaceuticals, Inc.1$21
Grifols USA, LLC1$21
Inspire Medical Systems, Inc.1$20
Optinose US, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,365 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$649,576
Medicare patients
1,512
Services billed
17,920

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban128$171,118
OzempicSemaglutide56$74,105
XareltoRivaroxaban61$68,646
JardianceEmpagliflozin50$63,938
ProliaDenosumab35$61,207
MyrbetriqMirabegron33$38,036
MounjaroTirzepatide35$36,454
JanuviaSitagliptin Phosphate23$28,474
TrulicityDulaglutide16$20,084
SynthroidLevothyroxine Sodium248$17,253
Victoza 3-PakLiraglutide11$14,973
PremarinEstrogens, Conjugated22$13,316
EntrestoSacubitril/Valsartan14$11,021
Levothyroxine Sodium1,151$10,848
Atorvastatin Calcium1,056$9,415

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$2,115$184,434150 claims
Novo NordiskOzempic$1,430$74,10556 claims
Johnson & JohnsonXarelto$950$68,64661 claims
Boehringer IngelheimJardiance$453$63,93850 claims
AmgenProlia$929$61,20735 claims
Lilly USA, LLCMounjaro, Trulicity$809$56,53851 claims
Astellas Pharma US IncMyrbetriq$1,082$38,03633 claims
MerckJanuvia$772$28,47423 claims
AbbVieSynthroid$1,764$17,253248 claims
NovartisEntresto$311$11,02114 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$32$10,8481,151 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$537$7,74216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →